Tobacco use: Clinical sciences

Last updated: January 30, 2025

Tobacco use: Clinical sciences

psych exam 2

psych exam 2

Cluster A personality disorders
Cluster B personality disorders
Cluster C personality disorders
Delusional disorder
Schizoaffective disorder
Schizophrenia
Schizophreniform disorder
Factitious disorder
Somatic symptom disorder
Alcohol use disorder
Cannabis use disorder
Cocaine use disorder
Opioid use disorder
Tobacco use disorder
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Drug misuse, intoxication and withdrawal: Other depressants: Pathology review
Drug misuse, intoxication and withdrawal: Stimulants: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Developmental and learning disorders: Pathology review
Malingering, factitious disorders and somatoform disorders: Pathology review
Personality disorders: Pathology review
Psychiatric emergencies: Pathology review
Schizophrenia spectrum disorders: Pathology review
Attention deficit hyperactivity disorder (ADHD): Clinical sciences
Autism spectrum disorder: Clinical sciences
Approach to antisocial, borderline, histrionic, and narcissistic (cluster B) personality disorders: Clinical sciences
Approach to avoidant, dependent, and obsessive-compulsive (cluster C) personality disorders: Clinical sciences
Approach to paranoid, schizoid, and schizotypal (cluster A) personality disorders: Clinical sciences
Substance use disorder: Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Approach to benzodiazepine and barbiturate use, intoxication, and overdose: Clinical sciences
Approach to hallucinogen, inhalant, and cannabis use, intoxication, and overdose: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid use disorder: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Tobacco use: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Schizophrenia and related disorders: Clinical sciences
Approach to somatic symptom and related disorders: Clinical sciences
Atypical antidepressants
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid antagonists

Decision-Making Tree

Transcript

Watch video only

Tobacco use disorder, or TUD for short, is a condition that develops after continued tobacco use, and it’s associated with nicotine dependence. These individuals have an increased risk of developing conditions like COPD, atherosclerosis, myocardial infarction, and sudden cardiac death. Now, based on the status of tobacco use, you can classify your patients into three main groups, including patients who never used tobacco, those who currently use tobacco, and former tobacco users.

Now, if a patient presents with a chief concern suggesting tobacco use disorder, your first step is to obtain a focused history and physical. Your patient will typically report a history of tobacco use, or they might report exposure to secondhand smoke. On physical exam, you will typically see signs, such as nicotine-stained fingertips or stained dentition.

At this point, you should suspect tobacco use disorder and assess the patient’s status of tobacco use. If your patient has never used tobacco, no further workup is needed, and your management should focus on prevention. This includes encouraging the patient to continue to abstain from smoking, and offering guidance on avoiding secondhand tobacco exposure.

On the other hand, if your patient is currently using tobacco, assess the DSM-V criteria for tobacco use disorder. To diagnose tobacco use disorder, your patient must present with at least two of the following criteria over 12 months.

First, your patient is consuming large amounts of tobacco over long periods. They have a persistent desire or effort to quit or cut down tobacco use. They are spending a considerable amount of time obtaining or using tobacco, and they have cravings and a strong desire to use tobacco.

Additionally, their tobacco use interferes with their daily responsibilities, but also with their social and occupational activities. Next, the patient continues to use tobacco despite it causing problems. They use tobacco in risky situations and continue to use it even after they develop physical and psychological problems.

The last two criteria include tolerance, meaning the patient needs to consume more tobacco to achieve the same effect; and lastly, withdrawal symptoms if tobacco is stopped, such as headaches, poor concentration, anxiety, or insomnia.

If your patient meets the DSM-V criteria, diagnose tobacco use disorder, and assess the patient's readiness to quit smoking. If your patient is not ready to quit, offer them motivational counseling, which is based on the 5 Rs. The first R stands for Relevance, which touches on the importance of stopping tobacco use, like addressing the patient’s current state of health or avoiding tobacco exposure for others in the household. The second one is for Risks, which covers the acute and long-term risks, like asthma exacerbation, respiratory infections, heart disease, stroke, and cancer.

Sources

  1. "Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons" JAMA (2021)
  2. "Treatment of Tobacco Smoking" JAMA (2022)
  3. "Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision" Washington, DC (2022)
  4. "Smoking Cessation: A Report of the Surgeon General" US Department of Health and Human Services (2020)
  5. "Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary" Respir Care (2008)